Menopause hormonal therapy in women with systemic lupus erythematosus
✍ Scribed by Jorge Sánchez-Guerrero; Marisol González-Pérez; Marta Durand-Carbajal; Pilar Lara-Reyes; Luisa Jiménez-Santana; Juanita Romero-Díaz; María-del-Carmen Cravioto
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 103 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective We sought to explore bladder dysfunction in a cohort of women with systemic lupus erythematosus (SLE). ## Methods We conducted a prospective study of 152 female patients with SLE during a 15‐month period. The clinical status of SLE was determined according to the SLE Dis
## Abstract ## Objective Systemic lupus erythematosus (SLE) occurs predominantly in women, and hormones may play a role in its etiology. This study was carried out to examine associations between female reproductive and menopausal factors and the development of SLE. ## Methods A cohort of 238,30
Objective. To measure salivary testosterone in women with systemic lupus erythematosus (SLE). Methods. We investigated concentrations of salivary testosterone in 13 women with active SLE and 47 women with inactive SLE, and in 72 healthy female controls. Results. We found a significant decrease in